Shuttle Pharmaceuticals Holdings, Inc.

GAITHERSBURG, MD · Founded 2018 · CIK 0001757499 · Software

Drug development decision-support platform for early-stage research

shuttlepharma.com →
Grants
—
No SBIR or STTR on record
Sector median: 0
Raised
$23M
9 Form D · May 2026
5 months since last filing
Contracts
—
No federal contracts on record
Patents
3
0 granted · 3 pending
Sector median: 0

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$912,500
Private capital raisedForm D · SEC$500,000
Private capital raisedForm D · SEC$365,000
Private capital raisedForm D · SEC$125,000
Private capital raisedForm D · SEC$4,000,000
Private capital raisedForm D · SEC$790,000
Private capital raisedForm D · SEC$4,250,000
Private capital raisedForm D · SEC$2,499,998
Private capital raisedForm D · SEC$9,955,000
Form D · SEC

Peer position

Software · 4096 companies · ranked on federal contract value
Software companies ranked by federal contract value
#CompanyContractsDisclosed equity
1235APOP, LLC—$25K
1236Epistemic AI, Inc.—$1.9M
1237Zesty. AI, Inc.—$35M
1238Shuttle Pharmaceuticals Holdings, Inc.—$23M
1239Citylitics Inc.—$4.1M
1240KERNEL LABS HOLDING LLC—$7.8M
1241LocaLoop, Inc.—$925K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 25 related persons
  • William AdkinsDirector
  • Milton BrownDirector · Executive Officer
  • Adam ChambersDirector
  • Christopher CooperDirector · Executive Officer
  • Peter DritschilloExecutive Officer
  • Anatoly DritschiloDirector · Executive Officer
  • Peter DritschiloDirector · Executive Officer
  • Amir HeshmatpourDirector
  • Bette JacobsDirector
  • Mira JungDirector · Executive Officer
  • Yuying LiangExecutive Officer
  • Angel LirianoDirector
  • Timothy LorberExecutive Officer
  • Oleh NabytDirector
  • Sachin PathigodaDirector
  • Tyvin RichExecutive Officer
  • Steven RichardsDirector
  • Josh SchaferDirector
  • Joshua SchaferDirector
  • George ScorcisDirector
  • George ScorsisDirector
  • Chris SenanayakeDirector
  • Ryan TrasoliniExecutive Officer
  • Joseph TungDirector
  • Michael Vander HoekExecutive Officer

Patents

USPTO · 0 granted of 3
  • Predictive Biomarkers For Adverse Effects Of Radiation Therapyapplication
  • Boron Containing Psma Ligand For Use In The Treatment Of Cancerapplication
  • Boron Containing Psma Ligand For Use In The Treatment Of Cancerapplication